Technical Articles
potency assay
Where AF647-Labeled GPC3 Sits in the CAR-T Development Chain
From target validation to CAR potency release, fluorescent GPC3 reagents support each stage of HCC cell-therapy development. This article maps the chain and the assay needs.
View details
- Cancer
- GPC3 CAR-T
- potency assay
- HCC cell therapy
- target validation
- fluorescent reagent
- UA011279
The CD19 Industry Line: From Autologous CAR-T to Off-the-Shelf and Bispecifics
CD19 anchors the largest CAR-T franchise. This article walks the industry chain: autologous manufacturing, allogeneic and in-vivo formats, bispecifics and where antigen reagents fit in.
View details
- Immunity/Inflamma
- CD19 industry
- CAR-T
- bispecific antibody
- off-the-shelf
- potency assay
- antigen reagent
- UA011126
- 1








